Gontivimab

Gontivimab
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T77027-1mg 1 mg - - -

7 - 10 business days*

183.00€
TGM-T77027-10mg 10 mg - - -

7 - 10 business days*

654.00€
TGM-T77027-25mg 25 mg - - -

7 - 10 business days*

1,023.00€
TGM-T77027-50mg 50 mg - - -

7 - 10 business days*

1,412.00€
 
Description: Gontivimab (ALX-0171) is a trivalent nanobody targeting the hRSV fusion (F) protein... more
Product information "Gontivimab"
Description: Gontivimab (ALX-0171) is a trivalent nanobody targeting the hRSV fusion (F) protein with anti-RSV antiviral properties for the study of respiratory syncytial virus infections. Target: RSV. References: Detalle L, et al. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015 Oct 5,60(1):6-13.
Keywords: VR-465 , ALX-0171 , VR465 , ALX0171
Supplier: TargetMol
Supplier-Nr: T77027

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Gontivimab"
Write a review
or to review a product.
Viewed